Literature DB >> 10326281

Resurgent and emergent disease in a changing world.

M L Cohen1.   

Abstract

Emerging infectious diseases pose important public health problems for both the developed and developing world. Many new or previously unrecognized bacterial, fungal, viral, and parasitic diseases have emerged within the past two decades. At the same time, many once-controlled infections have re-emerged or become resistant to antimicrobial therapy. This emergence is the result of changes in society, technology, the environment, and the microbes themselves, and these changes have had often unpredictable consequences. Important factors influencing emergence include changes in human demographics and behaviour, changes in technology and industry, changes in economic development and land use, increasing and rapid international travel and commerce, microbial adaptation and change, and the breakdown of public health measures. Addressing emerging infectious diseases will require international and interdisciplinary partnerships to build an appropriate infrastructure to detect and respond to these often unanticipated threats to health.

Entities:  

Mesh:

Year:  1998        PMID: 10326281     DOI: 10.1093/oxfordjournals.bmb.a011707

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  7 in total

1.  Density-dependent decline of host abundance resulting from a new infectious disease.

Authors:  W M Hochachka; A A Dhondt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Swine virome on rural backyard farms in Mexico: communities with different abundances of animal viruses and phages.

Authors:  Rodrigo Jesús Barrón-Rodríguez; Edith Rojas-Anaya; Jorge Tonatiuh Ayala-Sumuano; José Ángel Iván Romero-Espinosa; Joel Armando Vázquez-Pérez; Moisés Cortés-Cruz; Gary García-Espinosa; Elizabeth Loza-Rubio
Journal:  Arch Virol       Date:  2021-01-04       Impact factor: 2.574

3.  Shaping cities for health: complexity and the planning of urban environments in the 21st century.

Authors:  Yvonne Rydin; Ana Bleahu; Michael Davies; Julio D Dávila; Sharon Friel; Giovanni De Grandis; Nora Groce; Pedro C Hallal; Ian Hamilton; Philippa Howden-Chapman; Ka-Man Lai; C J Lim; Juliana Martins; David Osrin; Ian Ridley; Ian Scott; Myfanwy Taylor; Paul Wilkinson; James Wilson
Journal:  Lancet       Date:  2012-05-30       Impact factor: 79.321

4.  In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.

Authors:  K V Singh; K Malathum; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Molecular typing in public health laboratories: from an academic indulgence to an infection control imperative.

Authors:  Franz Allerberger
Journal:  J Prev Med Public Health       Date:  2012-01-31

6.  In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms.

Authors:  Balungile Madikizela; Ashwell Rungano Ndhlala; Jeffrey Franklin Finnie; Johannes Van Staden
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-05       Impact factor: 2.629

7.  Environmental determinants of infectious disease: a framework for tracking causal links and guiding public health research.

Authors:  Joseph N S Eisenberg; Manish A Desai; Karen Levy; Sarah J Bates; Song Liang; Kyra Naumoff; James C Scott
Journal:  Environ Health Perspect       Date:  2007-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.